SCF, recruit mast cells in the inflammatory site to selectively secrete proinflammatory molecules (22) (23) (24) (25) (26) (27) (28) . These could include growth factors, histamine, which is mitogenic (H 1) and an immunosuppressant (H2), neovascularization agents, such as heparin, VEGF and IL-8, as well as proteases that could permit new blood vessel formation (29) (30) . Mast cells degranulate and secrete molecules, such as IL-4 and TNF-alpha, which induce apoptosis, IL-6 and IL-1 (31) (32) (33) (34) (35) .
It has been shown that interleukin-1 (IL-1), one of the most studied cytokine, enhances IgEIAg-Fcslcl-mediated activation, including the secretion of Th2 cytokines in both human and mouse mast cells in vitro (36) (37) . Therefore, an understanding of mechanisms which regulate production and function of cytokines is very important and may result in the development of more effective methods of treatment of allergic diseases. Moreover, later it has been reported that IL-12 and IL-18 without TcR engagement can induce IFN-gamma in Thl cells and non-polarized T cells (38) .
The IL-1 family consists of at least 11 cytokines including IL-18 and IL-33. The latest one is IL-33/IL-1F 11,which is a ligand for T1IST2/1L-1 R4 expressed on mast cells and T helper 2 cells (39) . IL-33 is essential to host defences against severe infections and is a potent pro-inflammatory cytokine able to induce IL-4, IL-5, and IL-13 in immune competent cells (mouse Th2 cells) and can also induce NF-KB phosphorylation and MAP kinase activation (40) (41) . In addition, it has been reported that IL-1beta, IL-18 or IL-33 induced phosphorylation of Erk, p38 and JNK in naive human umbilical cord blood mast cells (HUCBMCs), and IL-33 or IL-lbeta, but not IL-18, enhanced the survival of naive HUCBMCs. IL-181 IL-18R signal is associated with phosphorylation of MAP kinase in mouse mast cells (42) .
IL-18, which is a member of the IL-l family, induces naive T cells to develop into Th2 cells. Therefore, IL-18 plays a part in the clearance of viruses, partly by the induction of cytotoxic T cells, and the expulsion of viruses is impaired in IL-18-deficient mice (43) (44) . IL-18 also enhances tumour rejection by its potent capacity to augment the cytotoxic activity of NK and T cells in vivo (45) . IL-18 should be seen as a unique cytokine that enhances innate immunity and both Thl-and Th2-driven immune responses (46) (47) . Inflammation is accelerated by IL-1 and initiated by over-release of IL-18, which also acts on B cells, NK cells, macrophages and dendritic cells to produce IFNgamma. Furthermore, IL-18 with IL-3 stimulates basophils and mast cells to produce Th2 cytokines (48) .
Mast cells playa crucial role in the development of allergy reactions, through cross-linking of their surface receptors for IgE (FCERI), leading to degranulation and release of vasoactive, proinflammatory mediators, cytokines and arachidonic acid products (49) . Mast cells are prominent in the airways and have been implicated in the pathophysiology of asthma by producing inflammatory mediators such as PGD2. PGD2 may act as a neuromodulator and as an allergic and inflammatory mediator (50) .
Recent evidence indicates that, in addition to the direct effect of these mast cell products, some mast cell mediators themselves modulate inflammatory mediator production. IL-33 might be also critically involved in pathogen-induced bronchial asthma, in which pathogens stimulate epithelial cells to produce IL-33 (33, 51) .
Moreover, IL-33 directly stimulates basophils and mast cells to produce cytokines and histamine independently of 19B. However, it has been proven that some other cytokines, such as IL-10 and cytokines from the IL-10 family, and TGF-beta have anti-inflammatory properties in allergy (52) (53) .
Mast cells are recognized as a new type of immunoregulatory cells capable of producing different cytokines. Mature human mast cells are tissue-residing, key effector cells of immediate allergic reactions. IL-33 induces biological effects on mast cells and T cells through its receptor IL-33R~-chain and may have pro-inflammatory potential effects similar to the cytokines from the same family (33) . Recently, it has been found that IL-33 stimulates in mast cells arachidonic acid product release, such as PGD2 and inflammatory cytokines including TNFa. However, these effects have been shown in activated mast cells and neither induced nor enhanced mast cell degranulation (54) . Mast cells have been recognized as a potent cellular source of multiple cytokines, suggesting an important role in immunoregulation and host defense (55) . Mast cells have long been recognized as the principal cell type that initiates the inflammatory response characteristic of acute allergic type 1 reactions. Although a great deal has been learned about the mediators produced by mast cells, the ultimate biologic function(s) of mast cells remains a mystery. Histamine, LTC4, PAF, and possibly tryptase (C3a generation) are mast cell products and all enhance vasopermeability. Mediators with anticoagulant activities such as heparin and tryptase (fibrinogenolysis) and antithrombotic activity, PGD2, would appear to facilitate dispersion in tissues of the plasma ultrafiltrate brought there by the subgroup of mediators that enhance vasopermeability (48, 56) . Early-phase or immediate reactions are largely the result of bronchoconstriction consequent to the release of mediators such as histamine, PGD2. The principal mediator cell (MC) is the mast cell (although other IgE receptor-bearing cells such as the macrophage, eosinophil and platelet might also be involved in this immediate response).
Addition of IL-33 to the human cord blood mast cell, activated with anti-IgE culture medium, induces the generation of PGD2, while IL-33 or anti-IgE alone has no effect (33) .
We observed that these cells express the proinflammatory PGD2 after anti-IgE plus IL-33 stimulation. Release of PGD2 is detectable at 2 min after challenge reaching a maximum at about 15 min. Histamine release is more rapid, achieving 50% of maximum at about 4 min compared to about 7 min for PGD2. Moreover, mast cells generate either PGD 2 or LTC 4 , while astrocytes have been shown to produce cysteinyl leukotrienes (57) (58) . The prostaglandins are synthesized via the cyclooxygenase pathway (59) (60) , whereas leukotrienes are synthesized via the 5-lipoxygenase pathway. It is well-known that in human mast cell different chemokines are able to stimulate release of histamine and generation of leukotrienes.
In summary, we show here that mature human mast cells produce pro-inflammatory PGD2 that may be up-regulated following triggering with IgE-independent agonists such as bacteria, whereas activation by IgE receptor cross-linking may results in the expression of Th2-type cytokines such as IL-4 which enhances the expression ofTh2-type cytokines and down-regulates proinflammatory cytokines (61) .
